Chongqing Zhifei Biological Products Co., Ltd. (SHE:300122)

SHE:300122 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	2,566	2,700	6,341	2,622	4,308	1,437
Trading Asset Securities	2.36	-	-	-	-	-
Cash & Short-Term Investments	2,569	2,700	6,341	2,622	4,308	1,437
Cash Growth	-54.01%	-57.41%	141.81%	-39.13%	199.68%	24.98%
Accounts Receivable	13,518	16,273	27,059	20,614	12,868	6,624
Other Receivables	11.32	10.95	7.8	8.39	6.87	9.07
Receivables	13,529	16,284	27,066	20,622	12,874	6,633
Inventory	21,015	22,218	8,986	8,020	7,385	3,406
Prepaid Expenses	6.24	8.11	9.73	-	0.59	5.04
Other Current Assets	28.44	82.61	111.37	148.53	185.63	55.67
Total Current Assets	37,147	41,293	42,514	31,413	24,754	11,537
Property, Plant & Equipment	5,211	5,371	5,120	4,693	3,557	2,387
Long-Term Investments	291	295	295	284.5	239	170
Goodwill	19.28	19.28	19.28	19.28	19.28	19.28
Other Intangible Assets	550.32	300.26	317.68	352.71	342.8	270.53
Long-Term Deferred Tax Assets	1,103	928.5	569.19	186.08	115.34	124.16
Long-Term Deferred Charges	1,452	1,514	1,088	731.97	485.04	402.79
Other Long-Term Assets	164.1	188.44	308.42	322.5	534.91	304.82
Total Assets	45,937	49,910	50,232	38,004	30,047	15,215
Accounts Payable	636.86	5,420	13,142	9,807	9,178	3,084
Accrued Expenses	382.34	866.78	1,673	1,240	1,090	501.54
Short-Term Debt	13,964	11,902	2,635	1,785	568.86	2,874
Current Portion of Long-Term Debt	143.56	83.83	36.41	-	-	-
Current Portion of Leases	7.26	9.81	10.2	9.81	0.25	-
Current Income Taxes Payable	-	80.33	434.59	347.7	933.25	323.7
Current Unearned Revenue	14.29	11.87	11.31	-	-	-
Other Current Liabilities	21.03	67.03	143.86	40.17	99.62	32.88
Total Current Liabilities	15,170	18,441	18,086	13,230	11,871	6,817
Long-Term Debt	276.63	347.59	328.08	210.64	236.41	-
Long-Term Leases	12.08	15.45	25.31	27.76	12.24	-
Long-Term Unearned Revenue	204.71	230.4	228.27	238.34	222.2	115.84
Long-Term Deferred Tax Liabilities	40.41	44.31	57.96	60.77	48.34	29.88
Other Long-Term Liabilities	-	-	-	-	-	4.35
Total Liabilities	15,704	19,079	18,726	13,768	12,390	6,967
Common Stock	2,394	2,394	2,400	1,600	1,600	1,600
Additional Paid-In Capital	-	-	47.96	207.96	207.96	207.96
Retained Earnings	27,840	28,437	29,058	22,428	15,849	6,441
Shareholders' Equity	30,234	30,831	31,506	24,236	17,657	8,249
Total Liabilities & Equity	45,937	49,910	50,232	38,004	30,047	15,215
Total Debt	14,404	12,359	3,035	2,033	817.76	2,874
Net Cash (Debt)	-11,835	-9,658	3,305	588.94	3,490	-1,437
Net Cash Growth	-	-	461.19%	-83.13%	-	-
Net Cash Per Share	-4.94	-4.03	1.38	0.25	1.45	-0.60
Filing Date Shares Outstanding	2,394	2,394	2,400	2,400	2,400	2,400
Total Common Shares Outstanding	2,394	2,394	2,400	2,400	2,400	2,400
Working Capital	21,978	22,852	24,428	18,183	12,883	4,720
Book Value Per Share	12.63	12.88	13.13	10.10	7.36	3.44
Tangible Book Value	29,664	30,511	31,169	23,864	17,295	7,959
Tangible Book Value Per Share	12.39	12.75	12.99	9.94	7.21	3.32
Buildings	2,673	2,634	2,522	1,705	1,042	1,014
Machinery	3,542	3,327	2,526	2,064	1,369	904.94
Construction In Progress	831.51	1,006	1,287	1,836	1,825	906.49

Source: S&P Global Market Intelligence. Standard template. Financial Sources.